Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia.
<h4>Background</h4>Preventing and treating post-acute sequelae of COVID-19 infection (PASC), commonly known as Long COVID, has become a public health priority. This study tests whether Paxlovid treatment in the acute phase of COVID-19 could help prevent the onset of PASC.<h4>Method...
| 发表在: | PLoS Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
Public Library of Science (PLoS)
2025-09-01
|
| 在线阅读: | https://doi.org/10.1371/journal.pmed.1004711 |
